Impact of Neutrophils on the Tissue Microenvironment During Intestinal Inflammation

Faiz Minhajuddin1, Sean P Colgan1,2, Ian M Cartwright1,2

  • 1Mucosal Inflammation Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Insights

Neutrophils (polymorphonuclear leukocytes, PMN) drive chronic inflammation and tissue damage in diseases like IBD. Targeting PMN pathways offers new precision therapies for restoring mucosal barrier function and resolving inflammation.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Neutrophils (polymorphonuclear leukocytes, PMN) are key innate immune cells that accumulate at mucosal surfaces during inflammation.
  • Sustained PMN activation disrupts epithelial barriers, remodels extracellular matrix, causes metabolic imbalance, and dysregulates the microbiome.
  • These PMN-driven processes contribute to persistent tissue injury and treatment resistance in chronic inflammatory diseases like inflammatory bowel disease (IBD).

Purpose of the Study:

  • To synthesize current evidence on how PMNs shape the inflamed mucosal microenvironment.
  • To highlight mechanisms of PMN recruitment, retention, survival, and effector functions.
  • To discuss PMN-driven metabolic and microbiome alterations and their impact on therapy response.

Main Methods:

  • Review of human mucosal biopsies and experimental models of intestinal inflammation.
  • Integration of data from single-cell, spatial, and metabolic profiling approaches.
  • Analysis of bidirectional crosstalk between PMNs and other tissue compartments.

Main Results:

  • PMNs are recruited, retained, and survive in inflamed mucosa, executing effector programs like ROS production and NET formation.
  • PMNs engage in complex crosstalk with epithelial, stromal, and immune cells.
  • PMN activity significantly impacts host metabolism and the gut microbiome, influencing inflammation chronicity and therapeutic outcomes.

Conclusions:

  • PMNs act as context-dependent regulators of mucosal pathology and repair.
  • PMN-centered pathways represent promising targets for precision therapies.
  • Targeting PMNs can restore barrier function and promote durable inflammatory resolution in IBD and other chronic inflammatory conditions.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Acute Inflammation I: Cellular Phase01:26

Acute Inflammation I: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...